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S U M M A R Y
Objectives: The aims of this study were to improve our understanding of the clinical forms of
presentation of acute Q fever in Spain and to determine any possible relationships with geographical and
seasonal factors.
Methods: This was a retrospective study of 183 cases of acute Q fever from three Spanish regions,
Catalonia, Canary Islands, and La Rioja.
Results: The main clinical form of presentation was hepatitis (49.2%), followed by isolate febrile
syndrome (31.7%) and pneumonia (19.1%). The proportion of cases presenting as pneumonia was
signiﬁcantly higher in La Rioja (40.7%) than in Catalonia (18.3%) or the Canary Islands (12.9%) (p = 0.001).
In Catalonia and the Canary Islands, most cases (52.1% and 57.6%, respectively) were diagnosed between
March and June, whereas in La Rioja, most cases (51.8%) occurred between November and February.
Overall, the proportion of cases presenting as pneumonia was signiﬁcantly higher in the period from
November to February (32.6%) than in the periods March–June (16.0%) and July–October (13.0%)
(p = 0.01).
Conclusions: Our results suggest the existence of seasonal differences in the presentation of acute Q fever
in Spain, with a higher proportion of pneumonic forms in the colder months. Furthermore, we conﬁrmed
the existence of geographical differences, with a higher proportion of pneumonic forms in the region of
La Rioja, in the north of the country.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Q fever is a worldwide zoonosis caused by Coxiella burnetii.1–3
Livestock, and to a lesser degree various wild mammals and
domestic animals, such as dogs and cats, constitute the main
reservoirs of this microorganism.3 Infected animals shed
C. burnetii in their feces, urine, milk, and birth products.1,4
Shedding to the environment occurs mainly during parturition
and abortion.2,5,6 The contaminated products form aerosols that
can be spread several kilometers by the wind.7 Thus, Q fever may
occur in urban areas, mainly as sporadic cases, but also as
outbreaks.8 Outbreaks usually occur in rural areas, often in
relation to the transfer or handling of cattle, sheep, or goats.9,10* Corresponding author. Tel.: +34 937839488; fax: +34 937003614.
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Inhalation of infectious aerosol particles constitutes the major
route of acquiring the disease, while ingestion of raw dairy
products is a minor route of transmission. Acquisition through
the skin or mucosal contact with contaminated products and
vertical transmission are very rare.1,2
Asymptomatic infection is common.1,10 Among the symptom-
atic patients, Q fever may present with acute or chronic clinical
manifestations, with endocarditis being the main manifestation of
the chronic form.1,11 Acute Q fever usually presents with fever,
chills, and headache that may be accompanied by pneumonia and/
or hepatitis. Meningoencephalitis, pericarditis, and myocarditis
are among the rare clinical manifestations.1,12–18
Regional variations in acute disease presentation have been
reported.1,2 The aims of this study were to improve our
understanding of the clinical forms of presentation of acute Q
fever in Spain and to determine their possible relationships with
geographical and seasonal factors.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Clinical presentation of acute Q fever according to seasonal period
Presentation form Period p-Valuea
November–February (43 cases), n (%) March–June (94 cases), n (%) July–October (48 cases), n (%)
Pneumonia 14 (32.6) 15 (16.0) 6 (13.0) 0.010
Hepatitis 19 (44.2) 46 (48.9) 25 (54.4) 0.45
Isolated fever 10 (23.2) 33 (35.1) 15 (32.6) 0.17
a Cases diagnosed between November and February compared with cases diagnosed in other periods.
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The study was conducted in three Spanish hospitals, located in
separate regions: (1) Terrassa Hospital, located in Catalonia
(northeast of Spain) serving a population of about 200 000
inhabitants, with a mainly urban distribution; (2) San Pedro
Hospital, located in La Rioja region (north of Spain, adjacent to the
Basque Country) serving a population of about 300 000 inhabi-
tants, with a predominantly suburban and rural distribution; (3)
Dr. Negrı´n Gran Canaria University Hospital, located in the Canary
Islands (Atlantic Ocean, 200 km from Africa) serving a population
of about 450 000 inhabitants with a balanced urban, suburban, and
rural distribution.
We reviewed the clinical records of all adult patients who had
acute Q fever diagnosed between 1995 and 2009 in Terrassa
(Catalonia) and La Rioja, and between 2005 and 2009 in Gran
Canaria, where the prevalence of Q fever is higher.19
Criteria for inclusion in the study were fever (axillary
temperature 38 8C) plus a serological diagnosis of Q fever by
means of immunoﬂuorescence assay (IFA), on the basis of any of
the following criteria: (1) seroconversion, deﬁned as the appear-
ance of phase II IgG antibodies against C. burnetii at a titer 1/160
in the convalescent phase following a negative antibody titer in the
acute phase; (2) a four-fold or greater rise between acute-phase
and convalescent-phase serum samples; (3) a titer of IgG
antibodies 1/320 in a single determination plus a positive IgM
titer; (4) a titer of IgG antibodies 1/320 in a single determination
in the absence of an alternative diagnosis. The case was considered
conﬁrmed when serological criterion 1, 2, or 3 was met, and as
probable when criterion 4 was met.
The clinical and epidemiological data were recorded. A chest X-
ray was obtained in every case. The following criteria were used to
classify the clinical presentation: (1) the patient was considered to
have pneumonia if there was a lung inﬁltrate on chest radiograph;
(2) the patient was considered to have hepatitis if the aspartate
aminotransferase level and/or alanine aminotransferase level was
more than twice as high as the reference value, without lung
involvement on chest X ray; (3) isolated febrile syndrome was
identiﬁed when fever was present without lung or hepatic
involvement or another focus of infection.Table 2
Seasonal distribution and clinical presentation in each region
Region 
Catalonia (71 cases), n (%) Gran C
Period
November–February 13 (18.3) 16 (18
March–June 37 (52.1) 49 (57
July–October 21 (29.5) 20 (23
Clinical presentation
Pneumonia 13 (18.3) 11 (12
Other presentations 58 (81.7) 74 (87
Patients admitted to hospital 61 27 
Pneumonia 12 (19.7) 8 (29
Other presentations 49 (80.3) 19 (70
a Cases from La Rioja compared with cases from Catalonia or Gran Canaria.To study seasonal differences, cases were grouped into three
periods, according to the date of presentation: November to
February, March to June, and July to October. This clustering was
performed taking into account that the months of November to
February are those with a lower average temperature in most
Spanish regions.
A descriptive analysis was performed using means and
standard deviations (SD). Statistical comparisons of categorical
variables were made by Chi-square test. A p-value of 0.05 or less
was considered statistically signiﬁcant. Statistical analyses were
performed using EpiData v. 3.1.
3. Results
Acute Q fever was diagnosed in 183 patients (164 conﬁrmed
cases and 19 probable cases), 147 of whom were male (80.3%). The
mean patient age was 42.1 years (SD 15.3 years). Seventy-one
cases were from Catalonia, 27 from La Rioja, and 85 from Gran
Canaria. Sixty-three patients (34.3%) lived in a rural area: 21.1% of
those in Catalonia, 40.7% of those in La Rioja, and 43.5% of those in
Gran Canaria. No epidemic outbreaks were recorded.
The clinical presentation of Q fever was pneumonia in 35 cases
(19.1%), hepatitis in 90 cases (49.2%), and isolated febrile
syndrome in 58 cases (31.7%). Of these, three had pericarditis
and one had myocarditis. Non-speciﬁc clinical manifestations
were headache in 107 cases (58.5%), arthromyalgia in 69 cases
(37.7%), nausea or vomiting in 32 cases (17.5%), diarrhea in 20
cases (10.9%), abdominal pain in 14 cases (7.7%), and pharyngo-
dynia in ﬁve cases (2.7%). One hundred and ten patients were
admitted to the hospital, and two patients required admission to
the intensive care unit. Two patients died from complications of
their underlying disease (liver cirrhosis and end-stage renal
disease).
As regards the seasonal distribution, 94 cases (51.4%) were
diagnosed between March and June, 46 cases (25.0%) between July
and October, and 43 cases (23.5%) between November and
February. The clinical presentation in the form of pneumonia
was signiﬁcantly more frequent in the period from November to
February than in the rest of the year (Table 1).p-Valuea
anaria (85 cases), n (%) La Rioja (27 cases), n (%)
.8) 14 (51.8) 0.0001
.6) 8 (29.6) 0.014
.5) 5 (18.5) 0.39
.9) 11 (40.7) 0.001
.1) 16 (59.3)
22
.6) 10 (45.5) 0.03
.4) 12 (54.5)
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presentation of acute Q fever in the three regions. Of note, the
proportion of cases that occurred between November and February
was signiﬁcantly higher in La Rioja than in the other two regions.
Likewise, the proportion of cases with pneumonia was signiﬁcant-
ly higher in this region than in the other two, and this difference
remained when considering only cases admitted to hospital.
4. Discussion
Coinciding with other Spanish series of Q fever,19–23 more than
half of the cases in our study occurred in the spring months. This
has been attributed to the fact that most births in cattle and sheep
take place during these months, a condition that is known to
release large amounts of C. burnetii.5,9 However, it is noteworthy
that most cases from La Rioja were diagnosed between November
and February. One possible explanation for this is that the
reproduction of sheep in this region is usually planned so that
deliveries occur in the run-up to the Christmas holidays, when a
suckling kid is traditionally eaten.
A predominance of males was observed in the three participat-
ing hospitals, which is common in most series of Q fever.6,7,12–14,19–
29 This has been attributed to an increased risk of occupational
exposure for men, but it is likely that hormonal factors also play a
role.30
It is known that there are regional variations in the predomi-
nant presenting form of acute Q fever.30 It has been suggested that
the clinical form could be related to differences in the infecting
strain,31 the inoculation dose, host factors, or the route of
infection.1 Pneumonia would predominate in cases acquired by
inhalation of infectious aerosol particles, whereas hepatitis would
predominate in cases acquired by ingestion of contaminated dairy
products.32
Our ﬁnding of an increased number of cases of Q fever
pneumonia during the colder months suggests a possible
relationship between clinical presentation and temperature or
other seasonal factors. It is conceivable that the cold and winter
viral infections increase the susceptibility of the respiratory
mucosa to C. burnetii, as with other pathogens such as Streptococcus
pneumoniae. In the vast majority of studies on Q fever from Spain,
febrile forms without pneumonia predominate,19–21,24–28 with the
exception of the series from the Basque Country, in the Spanish
north coast region, where pneumonic forms predominate.22,23,29 In
this regard, our ﬁnding of a signiﬁcantly higher proportion of
pneumonia in La Rioja, a region in the north, bordering the Basque
Country, is noteworthy. Moreover, it is likely that some of the
reported differences are biased due to the observer. So, pneumonic
forms predominate in the series from pneumology services, and
febrile forms, with or without hepatitis, are more frequent in the
series from internal medicine and infectious diseases services,
especially in centers with a speciﬁc protocol for the study of fever
of intermediate duration, which includes carrying out Q fever
serology.20,24,33
The main limitations of our study are its retrospective nature
and the fact that only cases from three Spanish regions were
included.
In conclusion, our results suggest the existence of seasonal
differences in the presentation of Q fever in Spain, with a higher
proportion of pneumonic forms in the winter months. Further-
more, we conﬁrmed the existence of geographical differences, with
a higher proportion of pneumonic forms in the region of La Rioja, in
the north of the country.
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